RAPID MICRO BIOSYSTEMS, INC.
RPIDdata completeness 100%6 fiscal years on fileRAPID MICRO BIOSYSTEMS, INC. earns about -77% on invested capital, but has diluted owners by 126% over 5 years — worth asking whether the growth reaches owners. The cash-flow models don't apply cleanly here — the ledger says why below.Whether it’s worth owning at today’s price is the last question — and yours to answer, below.
| Figure | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|
| Revenue | $23.2M1 | $17.1M2 | $22.5M3 | $28.1M4 | $33.6M4 |
| Net income | −$73.5M5 | −$60.8M6 | −$52.5M7 | −$46.9M8 | −$47.1M8 |
| Operating cash flow | −$55M9 | −$58.5M10 | −$45.1M11 | −$44.2M12 | −$31.1M12 |
| Capital expenditure | $3.22M13 | $6.74M14 | $1.85M15 | $1.37M16 | $850,00016 |
| Free cash flow (derived) | −$58.2M9 | −$65.3M10 | −$46.9M11 | −$45.5M12 | −$31.9M12 |
| Total debt | $017 | $017 | — | $018 | $18.9M18 |
| Cash & equivalents | $178.4M19 | $27.1M20 | $24.3M21 | $16.9M22 | $20M22 |
| Diluted shares | 19.8M | 42.5M | 43.0M | 43.6M | 44.7M |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
10 shares is a claim on $7.43 of net worth that earned you −$10.55 and generated −$7.14 of cash last year, against $4.23 of debt.
It earned an average -77% on invested capital over 5 years. Compare that to what it costs to fund the business.
seeing a moat in the numbers →Share count is up 126% over 5 years — owners have been diluted. Worth asking what they got for it.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
Different models answer different questions — which to trust when →
- 10-K · period ending 2021-12-31 · accession 0001380106-23-000016 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2022-12-31 · accession 0001380106-24-000073 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2023-12-31 · accession 0001380106-25-000058 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2024-12-31 · accession 0001380106-26-000034 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2021-12-31 · accession 0001380106-23-000016 (NetIncomeLoss)
- 10-K · period ending 2022-12-31 · accession 0001380106-24-000073 (NetIncomeLoss)
- 10-K · period ending 2023-12-31 · accession 0001380106-25-000058 (NetIncomeLoss)
- 10-K · period ending 2024-12-31 · accession 0001380106-26-000034 (NetIncomeLoss)
- 10-K · period ending 2021-12-31 · accession 0001380106-23-000016 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2022-12-31 · accession 0001380106-24-000073 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2023-12-31 · accession 0001380106-25-000058 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2024-12-31 · accession 0001380106-26-000034 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2021-12-31 · accession 0001380106-23-000016 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2022-12-31 · accession 0001380106-24-000073 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2023-12-31 · accession 0001380106-25-000058 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2024-12-31 · accession 0001380106-26-000034 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2021-12-31 · accession 0001380106-23-000016 (LongTermDebt)
- 10-K · period ending 2024-12-31 · accession 0001380106-26-000034 (LongTermDebtNoncurrent)
- 10-K · period ending 2021-12-31 · accession 0001380106-23-000016 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2022-12-31 · accession 0001380106-24-000073 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2023-12-31 · accession 0001380106-25-000058 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2024-12-31 · accession 0001380106-26-000034 (CashAndCashEquivalentsAtCarryingValue)